WHO describes Egypt's experience eradicating Hepatitis C as ‘pioneering’



Mon, 12 Dec 2022 - 10:18 GMT


Mon, 12 Dec 2022 - 10:18 GMT

CAIRO – 12 December 2022: Dr Naeema Al Gasseer, World Health Organization [WHO] Representative praised Egypt’s experience in launching health initiatives concerned with humans’ health in the first place.

She added in televised statements that comprehensive health coverage means promoting health through prevention of disease, availability of treatment, reduction of poverty, and easy access to treatment.

She stated that five years ago, Egypt was one of the countries with the highest rates of infection with the Hepatitis C virus, but it has now reached almost complete elimination of the disease.

Al Gasseer described Egypt’s experience as a ‘pioneer experience’ and indicates the optimal investment of available resources in the country.

She pointed out that Egypt has achieved a state of complementarity in dealing with the health file, explaining that the Egyptian health initiatives have had successful experiences.

Dr. Tedros Adhanom, Director-General of the World Health Organization [WHO], praised the Egyptian experience in confronting hepatitis C virus last September, as he explained in press statements that Egypt has tested millions of Egyptians and provided free treatment to the infected.

Egypt succeeded to be the first country in the world free of the Hepatitis C virus.

The Egyptian campaign to confront Hepatitis C virus was scheduled to end in 2030, however by 2022, the patients’ rate has depressed to less than 1%.

‘The 100 million Seha’ initiative, adopted by President Abdel Fattah al Sisi achieved global success in many health aspects, and was praised by the World Health Organization for its role in eliminating Hepatitis C, as Egypt's experience in eliminating Hepatitis C became a role model.

On World Hepatitis Day, the World Health Organization report stated that the proportion of children infected with chronic hepatitis B disease decreased to less than 1% in 2019, down from 5% in the pre-vaccination period (the period between 1980 and early 2000), according to the new estimates of the organization.

He stressed that the new drugs have transformed hepatitis C disease from a serious disease to a disease that can be cured in 12 months.

He pointed out that the world has achieved an important achievement, which is to reach the global goal of reducing the spread of hepatitis C among children under five years of age by 2020. Which eliminates cases of cirrhosis and liver cancer for future generations.

 The report confirmed that the vaccine provides protection of more than 95% against infection, and therefore WHO recommends that all infants receive a first dose of hepatitis B vaccine as soon as after birth, preferably within 24 hours, followed by at least two additional doses.




Leave a Comment

Be Social